(A) Samples for serum N-glycome analysis.
| Patient Group |
BC |
Control |
p-value* |
| No. of Patients |
45 |
29 |
- |
| Age (y) |
70.4±8.99 |
66.1±5.87 |
0.026 |
Pathological T stage
Tis
Ta
T1
T1is
T2a
T2b
T3b
T4a |
9
12
11
1
4
1
5
2 |
|
|
Tumor Grade
G2
G3 |
13
32 |
|
|
Treatment
TUR
TUR, Radiation
Cystectomy |
30
2
13 |
|
|
|
| (B) Samples for serum O-glycome analysis. |
| Patient Group |
BC |
Control |
p-value* |
| No. of Patients |
13 |
10 |
- |
| Age (y) |
69.9±9.20 |
71.3±4.24 |
0.71 |
Pathological T stage
T1
T2a
T2b
T3b
T4a |
1
4
1
5
2 |
|
|
Pathological N stage
pN0
pN2
pN3 |
7
2
1 |
|
|
Tumor Grade
G2
G3 |
1
12 |
|
|
Treatment
TUR
TUR, Radiation
Cystectomy |
1
2
10 |
|
|
|
| (C) Samples for urine N- and O-glycome analysis. |
| Patient Group |
BC |
Control |
p-value* |
| No. of Patients |
8 |
11 |
- |
| Age (y) |
69.4±9.25 |
72.5±5.95 |
0.48 |
Urine Cytology (class)
2
3≦ |
4
4 |
|
|
Pathological T stage
T2a
T3b
T4a |
4
3
1 |
|
|
Pathological N stage
pN0
pN2
pN3 |
4
1
1 |
|
|
Tumor Grade
G2
G3 |
1
7 |
|
|
Treatment
TUR, Chemotherapy
TUR, Radiation
Cystectomy |
1
1
6 |
|
|
|
| Table 1: Patient’s characteristics. |
